Physician profile
David E Samuel
NPI 1053491837
$8,786.82
in general payments reported to CMS, 2019-2025
18 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $44.72 · 2021: $155 · 2022: $1,758 · 2023: $306 · 2024: $5,158 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,300 · Food and Beverage: $1,739 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,300.00 |
| Food and Beverage | $1,739.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $427.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $3,550.00 | 2023-2024 | Exparel, Iovera, Zilretta |
| Treace Medical Concepts, INC. | $1,942.15 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $1,000.00 | 2024 | Tazverik |
| Smith+Nephew, INC. | $521.53 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Organogenesis INC. | $388.32 | 2019-2025 | Puraply, Cygnus Dual, Via Matrix |
| Stryker Corporation | $339.65 | 2019-2025 | Augment Injectable, Prostep Mica, Ortholoc 2 Lapifuse |
| Paratek Pharmaceuticals, INC. | $243.09 | 2021-2025 | Nuzyra |
| Acera Surgical, INC. | $200.12 | 2022 | |
| The Institute of Musculoskeletal Science and Education | $155.53 | 2019 | |
| Kerecis Limited | $148.27 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stability Biologics, LLC | $135.00 | 2025 | |
| Integra Lifesciences Corporation | $38.06 | 2019-2020 | |
| Wright Medical Technology, INC. | $32.22 | 2019 | |
| Acumed LLC | $25.91 | 2019 | |
| Zimmer Biomet Holdings, INC. | $21.17 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.30 | 2025 | Activ.A.C. |
| Paragon 28, INC. | $15.11 | 2025 | Mtp |
| Orthofix Medical, INC. | $10.39 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.